Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...
Harbour BioMed, a global biopharmaceutical company, has announced a multi-year, global strategic collaboration and license ...
Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...
MEDI&GENE, a biopharmaceutical company, has entered into a Catalyze agreement with Eli Lilly and Company to advance a ...
Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.
Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback